Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders

European Journal of Human Genetics

Volumn 20, Issue 2, 2012, Pages 198-202

  McWhirter, Rebekah E ^a   McQuillan, Ruth ^a   Visser, Elizabeth ^b   Counsell, Carl ^b   Wilson, James F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

genetic risk factors; homozygosity; multiple sclerosis; Orkney and Shetland Islands

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; CONSANGUINITY; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; INBREEDING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RISK FACTORS; SCOTLAND; YOUNG ADULT;

EID: 84855809706     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.170     Document Type: Article

References (37)

1. Sawcer S, Ban M, Maranian M et al: A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005; 77: 454-467. (Pubitemid 41192651)
2. Olerup O, Hillert J: HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991; 38: 1-15.
3. Naito S, Namerow N, Mickey MR, Terasaki PI: Multiple sclerosis: association with HL-A3. Tissue Antigens 1972; 2: 1-4.
4. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL: The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 2008; 9: 516-526. (Pubitemid 351861542)
5. Oksenberg JR, Barcellos LF, Cree BAC et al: Mapping multiple sclerosis susceptibility to the HLA-DR locus in African-Americans. Am J Hum Genet 2004; 74: 160-167. (Pubitemid 38085247)
6. Reich D, Patterson N, De Jager PL et al: A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Nat Genet 2005; 37: 1113.
7. Chao MJ, Barnardo MCNM, Lincoln MR et al: HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci USA 2008; 105: 13069-13074.
8. Rosati G: The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001; 22: 117-139. (Pubitemid 33771279)
9. Roberts DF: Consanguinity and multiple sclerosis in Orkney. Genet Epidemiol 1991; 8: 147-151.
10. Roberts DF, Papiha SS, Poskanzer DC: Polymorphisms and multiple sclerosis in Orkney. J Epidemiol Commun H 1979; 33: 236-242. (Pubitemid 10199464)
11. Roberts DF, Roberts MJ, Poskanzer DC: Genetic analysis of multiple sclerosis in Shetland. J Epidemiol Commun H 1983; 37: 281-285. (Pubitemid 14200489)
12. Roberts DF, Roberts MJ, Poskanzer DC: Genetic analysis of multiple sclerosis in Orkney. Br Med J 1979; 33: 229-235. (Pubitemid 10199463)
13. Dean G, Goodall J, Downie A: The prevalence of multiple sclerosis in the Outer Hebrides compared with north-east Scotland and the Orkney and Shetland Islands. J Epidemiol Commun H 1981; 35: 110-113. (Pubitemid 11066743)
14. Poskanzer D, Terasaki PI, Prenney LB, Sheridan JL, Park MS: Multiple sclerosis in the Orkney and Shetland Islands III: histocompatibility determinants. J Epidemiol Commun H 1980; 34: 253-257. (Pubitemid 11207396)
15. Poskanzer DC, Prenney LB, Sheridan JL, Kondy JY: Multiple sclerosis in the Orkney and Shetland Islands. I: epidemiology, clinical factors, and methodology. J Epidemiol Commun H 1980; 34: 229-239. (Pubitemid 11207394)
16. Poskanzer DC, Sever JL, Sheridan JL, Prenney LB: Multiple sclerosis in the Orkney and Shetland Islands. IV: viral antibody titres and viral infections. J Epidemiol Commun H 1980; 34: 258-264. (Pubitemid 11207397)
17. Poskanzer DC, Sever JL, Terasaki PI, Prenney LB, Sheridan JL, Park MS: Multiple sclerosis in the Orkney and Shetland Islands. V: the effect on viral titres of histocompatibility determinants. J Epidemiol Commun H 1980; 34: 265-270. (Pubitemid 11207398)
18. Poskanzer DC, Sheridan JL, Prenney LB, Walker AM: Multiple sclerosis in the Orkney and Shetland Islands. II: the search for an exogenous aetiology. J Epidemiol Commun H 1980; 34: 240-252. (Pubitemid 11207395)
19. Poskanzer DC, Walker AM, Yonkondy J, Sheridan JL: Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology 1976; 26: 14-17.
20. Taylor R, Illsley R, Poskanzer DC: Multiple sclerosis in the Orkney and Shetland Islands. VI: the effects of migration and social structure. J Epidemiol Commun H 1980; 34: 271-276. (Pubitemid 11207399)
21. Hoppenbrouwers IA, Pardo Cortes LM, Aulchenko YS et al: Familial clustering of multiple sclerosis in a Dutch genetic isolate. Mult Scler 2007; 13: 17-24. (Pubitemid 46152757)
22. Sadovnick AD, Yee IML, Ebers GC: Recurrence risks to sibs of MS index cases: impact of consanguineous matings. Neurology 2001; 56: 784-785. (Pubitemid 32240102)
23. Tienari PJ, Sumelahti M-L, Rantamäki T, Wikström J: Multiple sclerosis in western Finland: evidence for a founder effect. Clin Neurol Neurosurg 2004; 106: 175-179. (Pubitemid 38716144)
24. Callander M, Landtblom A-M: A cluster of multiple sclerosis in Lysvik in the Swedish county of Värmland. Acta Neurol Scand 2004; 110: 14-22. (Pubitemid 38850551)
25. Botstein D, Risch N: Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003; 33: 228-237. (Pubitemid 36278833)
26. Van Duijn CM, Dekker MCJ, Bonifati V et al: PARK7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet 2001; 69: 629-634. (Pubitemid 32777700)
27. Ewald H, Wikman FP, Teruel BM et al: A genome-wide search for risk genes using homozygosity mapping and microarrays with 1,494 single-nucleotide polymorphisms in 22 eastern Cuban families with bipolar disorder. Am J Med Genet B 2004; 133: 25-30. (Pubitemid 40175610)
28. McQuillan R: Homozygosity, Inbreeding and Health in European Populations, PhD thesis, University of Edinburgh, Edinburgh, UK, 2009.
29. McQuillan R, Leutenegger AL, Abdel-Rahman R et al: Runs of homozygosity in European populations. Am J Hum Genet 2008; 83: 359-372.
30. Kurtzke JF: Rating neurologic impairment in multiple sclerosis; an expanded disability status scale (EDSS). Neurology 1983; 33: 1445-1452.
31. Poser CM, Paty DW, Scheinberg L et al: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231. (Pubitemid 13158528)
32. McDonald WI, Compston A, Edan G et al: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
33. Polman CH, Reingold SC, Edan G et al: Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol 2005; 58: 840-846. (Pubitemid 41746873)
34. Purcell S, Neale B, Todd-Brown K et al: PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
35. R Development Core Team: R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2008. http://www.R-project.org.
36. Roberts DF: Report on the Genetic Analysis of Multiple Sclerosis in the Orkney and Shetland Islands. National Institutes of Health, 1979.
37. Hildebrandt F, Heeringa SF, Rüschendorf F et al: A systematic approach to mapping recessive disease genes in individuals from outbred populations. PLoS Genet 2009; 5: e1000353.